drugset / Trial / NCT01438034

Kisspeptin in the Evaluation of Delayed Puberty

NCT01438034

Phase 1 Completed 24 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelOther

Summary

The goal of this study is to test whether the hormone kisspeptin has the potential to prospectively diagnose adolescents with self-resolving or permanent delayed puberty. Some children with delayed puberty will eventually enter puberty on their own. However, some children with delayed puberty have a permanent condition and require medical treatment to undergo puberty. Right now, there is no reliable diagnostic tool to tell whether a child's delayed puberty will be self-resolving or permanent. The hormone kisspeptin has the potential to prospectively diagnose adolescents with self-resolving or permanent delayed puberty.

Timeline

Start
2013-06-08
Primary completion
2019-09-08
Completion
2021-09-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Gonadorelin Protein / enzyme biologic 75 ng Intravenous
Subject kisspeptin 112-121 Peptide 0.24 unknown Intravenous

Indications